Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Open-label, Study to Evaluate the Efficacy and Tolerability of the Food Supplement CELERGEN in Patients With Fibromyalgia

NCT03911882 is registered in ClinicalTrials.gov with Celergan SA as lead sponsor.

NCT NCT03911882
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03911882 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Open-label, Study to Evaluate the Efficacy and Tolerability of the Food Supplement CELERGEN in Patients With Fibromyalgia
Lead sponsor
Celergan SA
Phase
Observational
Overall status
Completed
Start date
April 29, 2016
Completion date
August 30, 2016
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fibromyalgia